Yarrow Bioscience, Inc.: RTW Fund Group GP, LLC amends Schedule 13G stake filing
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
RTW Fund Group GP, LLC amended its Schedule 13G stake filing for Yarrow Bioscience, Inc., according to SEC accession 0002147397-26-000003. The filing updates the fund group's reported ownership position in the biotech company. The amendment signals a change in RTW's disclosed holdings, though the filing summary did not specify the revised share count or percentage. Investors should watch for the full filing details to see whether the adjustment reflects passive portfolio rebalancing or a shift in conviction.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
RTW Fund Group GP, LLC, Yarrow Bioscience, Inc.